PRTK
Paratek Pharmaceuticals, Inc.
PRTK
PRTK
Delisted
PRTK was delisted on the 20th of September, 2023.
90 hedge funds and large institutions have $245M invested in Paratek Pharmaceuticals, Inc. in 2016 Q2 according to their latest regulatory filings, with 33 funds opening new positions, 38 increasing their positions, 7 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
33% more funds holding in top 10
Funds holding in top 10: 3 → 4 (+1)
15% more capital invested
Capital invested by funds: $213M → $245M (+$31.2M)
Holders
90
Holding in Top 10
4
Calls
$2.08M
Puts
$1.33M
Top Buyers
| 1 | +$8M | |
| 2 | +$6.96M | |
| 3 | +$6.42M | |
| 4 |
NI
Numeric Investors
Boston,
Massachusetts
|
+$4.33M |
| 5 |
BC
Broadfin Capital
New York
|
+$3.8M |
Top Sellers
| 1 | -$6.92M | |
| 2 | -$3.84M | |
| 3 | -$3.29M | |
| 4 |
AC
Aisling Capital
New York
|
-$2.78M |
| 5 |
NMC
NEA Management Company
Timonium,
Maryland
|
-$817K |